Selecting a prognostic renal surrogate for patients with hepatocellular carcinoma undergoing transarterial chemoembolization

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue 10, 2012, Pages 1581-1588

  Lee, Yun Hsuan ^a,b   Hsu, Chia Yang ^a,b   Huang, Yi Hsiang ^a,b   Su, Chien Wei ^a,b   Lin, Han Chieh ^a,b   Lee, Rheun Chuan ^a,b   Chiou, Yi You ^a,b   Huo, Teh Ia ^a,b   Lee, Shou Dong ^b,c  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CHENG HSIN GENERAL HOSPITAL   (Taiwan)

Author keywords

Chronic kidney disease epidemiology collaboration; Estimated glomerular filtration rate; Hepatocellular carcinoma; Modification of diet in renal disease; Renal insufficiency; Transarterial chemoembolization

Indexed keywords

CREATININE; SERUM ALBUMIN; SODIUM;

ADULT; AGED; AKAIKE INFORMATION CRITERION; ALBUMIN BLOOD LEVEL; ALCOHOLISM; ARTICLE; CANCER INVASION; CANCER OF THE LIVER ITALIAN PROGRAM SCORE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHILD TURCOTTE PUGH SCORE; CHRONIC KIDNEY DISEASE EPIDEMIOLOGY COLLABORATION; CLINICAL ASSESSMENT TOOL; CREATININE BLOOD LEVEL; DISEASE MARKER; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; KIDNEY FAILURE; LIVER CELL CARCINOMA; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MODIFICATION OF DIET IN RENAL DISEASE; PRIORITY JOURNAL; PROTHROMBIN TIME; RETROSPECTIVE STUDY; SCORING SYSTEM; SODIUM BLOOD LEVEL; STATISTICAL PARAMETERS; TUMOR VOLUME;

EID: 84866551420     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2012.07151.x     Document Type: Article

References (38)

1. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N. Engl. J. Med. 1999; 340: 745-50.
2. Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127: S5-16.
3. El-Serag HB, Marrero JA, Rudolph L, Reddy KR. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 2008; 134: 1752-63.
4. Llovet JM, Real MI, Montana X etal. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002; 359: 1734-9.
5. Tang ZY. Hepatocellular carcinoma. J. Gastroenterol. Hepatol. 2000; 15 (Suppl.): G1-7.
6. Llovet JM. Evidence-based medicine in the treatment of hepatocellular carcinoma. J. Gastroenterol. Hepatol. 2002; 17 (Suppl. 3): S428-33.
7. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis. 2002; 39: S1-266.
8. Chacko EC, Surrun SK, Mubarack Sani TP, Pappachan JM. Chronic viral hepatitis and chronic kidney disease. Postgrad. Med. J. 2010; 86: 486-92.
9. Mackelaite L, Alsauskas ZC, Ranganna K. Renal failure in patients with cirrhosis. Med. Clin. North Am. 2009; 93: 855-69.
10. Galossi A, Guarisco R, Bellis L, Puoti C. Extrahepatic manifestations of chronic HCV infection. J. Gastrointestin. Liver Dis. 2007; 16: 65-73.
11. Hussain SA, Ferry DR, El-Gazzaz G etal. Hepatocellular carcinoma. Ann. Oncol. 2001; 12: 161-72.
12. Huo TI, Wu JC, Huang YH etal. Acute renal failure after transarterial chemoembolization for hepatocellular carcinoma: a retrospective study of the incidence, risk factors, clinical course and long-term outcome. Aliment. Pharmacol. Ther. 2004; 19: 999-1007.
13. Huo TI, Wu JC, Lee PC, Chang FY, Lee SD. Incidence and risk factors for acute renal failure in patients with hepatocellular carcinoma undergoing transarterial chemoembolization: a prospective study. Liver Int. 2004; 24: 210-15.
14. Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ. Nephrotoxic effects in high-risk patients undergoing angiography. N. Engl. J. Med. 2003; 348: 491-9.
15. Parfrey PS, Griffiths SM, Barrett BJ etal. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N. Engl. J. Med. 1989; 320: 143-9.
16. Coresh J, Selvin E, Stevens LA etal. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-47.
17. Hsu CY, Huang YH, Su CW etal. Renal failure in patients with hepatocellular carcinoma and ascites undergoing transarterial chemoembolization. Liver Int. 2010; 30: 77-84.
18. Hsu CY, Huang YH, Su CW etal. Transarterial chemoembolization in patients with hepatocellular carcinoma and renal insufficiency. J. Clin. Gastroenterol. 2010; 44: e171-7.
19. Huo TI, Wu JC, Lee PC etal. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology 1998; 28: 231-6.
20. Hsu CY, Huang YH, Su CW etal. Differential prognostic impact of renal insufficiency on patients with hepatocellular carcinoma: a propensity score analysis and staging strategy. J. Gastroenterol. Hepatol. 2012 27: 690-9.
21. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann. Intern. Med. 1999; 130: 461-70.
22. Levey AS, Coresh J, Greene T etal. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann. Intern. Med. 2006; 145: 247-54.
23. Levey AS, Stevens LA, Schmid CH etal. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 2009; 150: 604-12.
24. Bruix J, Sherman M, Llovet JM etal. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J. Hepatol. 2001; 35: 421-30.
25. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-36.
26. Grant BF, Dufour MC, Harford TC. Epidemiology of alcoholic liver disease. Semin. Liver Dis. 1988; 8: 12-25.
27. Bellentani S, Saccoccio G, Costa G etal. Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut 1997; 41: 845-50.
28. Hsu CY, Huang YH, Hsia CY etal. A new prognostic model for hepatocellular carcinoma based on total tumor volume: the Taipei Integrated Scoring System. J. Hepatol. 2010; 53: 108-17.
29. Kikuchi LO, Paranagua-Vezozzo DC, Chagas AL etal. Nodules less than 20 mm and vascular invasion are predictors of survival in small hepatocellular carcinoma. J. Clin. Gastroenterol. 2009; 43: 191-5.
30. The Cancer of the Liver Italian Program (CLIP) Investigators. Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 2000; 31: 840-5.
31. Wiesner R, Edwards E, Freeman R etal. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91-6.
32. Levey AS, Coresh J, Greene T etal. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin. Chem. 2007; 53: 766-72.
33. Feinstein AR. Clinical biostatistics. XVI. The process of prognostic stratification. 2. Clin. Pharmacol. Ther. 1972; 13: 609-24.
34. Hosmer DW, Hosmer T, Le Cessie S, Lemeshow S. A comparison of goodness-of-fit tests for the logistic regression model. Stat. Med. 1997; 16: 965-80.
35. Forster MR. Key concepts in model selection: performance and generalizability. J. Math. Psychol. 2000; 44: 205-31.
36. Camargo EG, Soares AA, Detanico AB etal. The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation is less accurate in patients with Type 2 diabetes when compared with healthy individuals. Diabet. Med. 2011; 28: 90-5.
37. Marcellin P, Pequignot F, Delarocque-Astagneau E etal. Mortality related to chronic hepatitis B and chronic hepatitis C in France: evidence for the role of HIV coinfection and alcohol consumption. J. Hepatol. 2008; 48: 200-7.
38. Stevens LA, Coresh J, Feldman HI etal. Evaluation of the modification of diet in renal disease study equation in a large diverse population. J. Am. Soc. Nephrol. 2007; 18: 2749-57.